Evidence map›Paper›PMID 26849048›Full record

ArticlePLoS neglected tropical diseases2016

Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.

Bing-Cheng Zhao, Hong-Ye Jiang, Wei-Ying Ma, Da-Di Jin, Hao-Miao Li, Hai Lu, Hideaki Nakajima, Tong-Yi Huang, Kai-Yu Sun, Shu-Ling Chen and 1 more

Open access · goldAbstract readNetwork Meta-Analysis
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Article
  5. Article
  6. Frequency and Determinant Factors for Calcification in Neurocysticercosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  7. Review
  8. Article
  9. Unique Characteristics of Epilepsy Development in Neurocysticercosis.The American journal of tropical medicine and hygiene · 2020
    Review
  10. Review
  11. Review
  12. Optimal Treatment for Subarachnoid Neurocysticercosis: Closer, but Not There yet.The American journal of tropical medicine and hygiene · 2020
    Article
  13. Article
  14. Controlling the Host Response in Neurocysticercosis.The American journal of tropical medicine and hygiene · 2019
    Article
  15. Article
  16. Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis.International journal of chronic obstructive pulmonary disease · 2017
    Review
  17. Article
  18. Update on the Diagnosis and Management of Neurocysticercosis.Current infectious disease reports · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Bing-Cheng ZhaoDepartment of Clinical Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Hong-Ye JiangDepartment of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Wei-Ying MaDepartment of Anesthesiology, the Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Da-Di JinDepartment of Orthopedics, the Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Hao-Miao LiDepartment of Orthopedics, the Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Hai LuDepartment of Orthopedics, the Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Hideaki NakajimaDepartment of Orthopedics and Rehabilitation Medicine, Fukui University of Medical Sciences, Fukui, Japan.
Tong-Yi HuangDepartment of Clinical Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Kai-Yu SunDepartment of Clinical Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Shu-Ling ChenDepartment of Clinical Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Ke-Bing ChenDepartment of Orthopedics, the Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Sun Yat-sen University · CNThird Affiliated Hospital of Southern Medical University · CNUniversity of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSolitary cysticercus granuloma (SCG) is the commonest form of neurocysticercosis in the Indian subcontinent and in travelers. Several different treatment options exist for SCG. We conducted a Bayesian network meta-analysis of randomized clinical trials (RCTs) to identify the best treatment option to prevent seizure recurrence and promote lesion resolution for patients with SCG. METHODS AND PRINCIPAL

findingsPubMed, EMBASE and the Cochrane Library databases (up to June 1, 2015) were searched for RCTs that compared any anthelmintics or corticosteroids, alone or in combination, with placebo or head to head and reported on seizure recurrence and lesion resolution in patients with SCG. A total of 14 RCTs (1277 patients) were included in the quantitative analysis focusing on four different treatment options. A Bayesian network model computing odds ratios (OR) with 95% credible intervals (CrI) and probability of being best (Pbest) was used to compare all interventions simultaneously. Albendazole and corticosteroids combination therapy was the only regimen that significantly decreased the risk of seizure recurrence compared with conservative treatment (OR 0.32, 95% CrI 0.10-0.93, Pbest 73.3%). Albendazole and corticosteroids alone or in combination were all efficacious in hastening granuloma resolution, but the combined therapy remained the best option based on probability analysis (OR 3.05, 95% CrI 1.24-7.95, Pbest 53.9%). The superiority of the combination therapy changed little in RCTs with different follow-up durations and in sensitivity analyses. The limitations of this study include high risk of bias and short follow-up duration in most studies.

conclusionsDual therapy of albendazole and corticosteroids was the most efficacious regimen that could prevent seizure recurrence and promote lesion resolution in a follow-up period of around one year. It should be recommended for the management of SCG until more high-quality evidence is available.

Indexed as

AdolescentAdrenal Cortex HormonesAlbendazoleAnimalsAnthelminticsChildCysticercusDrug Therapy, CombinationFemaleGranulomaHumansMaleRandomized Controlled Trials as TopicTreatment OutcomeYoung AdultAdrenal Cortex HormonesAlbendazoleAnthelmintics

Identifiers

PMID26849048
PMCPMC4744042
OpenAlexW2254189315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.